|
Occupational
Exposure to Bloodborne Pathogens; Needlestick and Other
Sharps
Injuries; Final Rule. - 66:5317-5325
Federal
Register - Table of Contents
Information Date: 01/18/2001
Federal
Register #: 66:5317-5325
Standard
Number: 1904 ;1904.6 ;1910 ;1910SubpartZ ;1910.1000 ;1910.1001
;1910.1002 ;1910.1018
;1910.1029
;1910.1030 ;1910.1200 ;1911 ;1915.1030
Type:
Final
Agency:
OSHA
Subject:
Occupational Exposure to Bloodborne Pathogens; Needlestick and Other
Sharps Injuries; Final Rule.
CFR Title:
29
DEPARTMENT OF
LABOR
Occupational
Safety and Health Administration
29 CFR Part
1910
[Docket No.
H370A]
RIN 1218-AB85
Occupational
Exposure to Bloodborne Pathogens; Needlestick and Other Sharps
Injuries; Final Rule
AGENCY:
Occupational Safety and Health Administration (OSHA), Department of
Labor
ACTION: Final
Rule; Request for Comment on the Information Collection (Paperwork)
Requirements
SUMMARY: The
Occupational Safety and Health Administration is revising the
Bloodborne Pathogens standard in conformance
with the requirements of the Needlestick Safety and Prevention Act.
This Act directs OSHA to revise the Bloodborne
Pathogens standard to include new examples in the definition of
engineering controls along with two new definitions; to
require that Exposure Control Plans reflect how employers implement
new developments in control technology; to require
employers to solicit input from employees responsible for direct
patient care in the identification, evaluation, and selection of
engineering and work practice controls; and to require certain
employers to establish and maintain a log of percutaneous
injuries from contaminated sharps.
DATES:
Effective Date: The effective date is April 18, 2001. Written
comments: Written comments on the Information Collection
Requirements must be submitted on or before March 19, 2001.
ADDRESSES:
Copies of materials in the docket may be obtained from the OSHA
Docket Office, Room N-2625, U.S. Department of
Labor, 200 Constitution Avenue, NW., Washington, DC 20210, Telephone
(202) 693- 2350. Referenced documents are
included in Docket H370A and are identified by the exhibit number
indicated.
Submit written
comments on the Information Collection Requirements to the Docket
Office, Docket No. ICR-0180 (2001), OSHA, U.S.
Department of Labor, Room N-2625, 200 Constitution Avenue, NW.,
Washington, DC 20210; telephone: (202) 693-2350.
Commenters may transmit written comments of 10 pages or less in
length by facsimile to (202) 693-1648.
In compliance
with 28 U.S.C. 2112(a), the Agency designates the Associate
Solicitor for Occupational Safety and Health, Office of the
Solicitor, Room S-4004, U.S. Department of Labor, 200 Constitution
Avenue, NW., Washington, DC 20210, as the
recipient of petitions for review of the standard.
FOR FURTHER
INFORMATION CONTACT: Bonnie Friedman, Director, OSHA Office of
Public Affairs, Room N-3647, U.S.
Department of Labor, 200 Constitution Avenue, NW., Washington, DC
20210. Telephone: (202) 693- 1999.
SUPPLEMENTARY
INFORMATION:
I. Events
Leading to the Amended Final Rule
Blood and other
potentially infectious materials have long been recognized as a
potential threat to the health of employees who are exposed
to these materials by percutaneous contact (penetration of the
skin). Injuries from contaminated needles and other
sharps have been associated with an increased risk of disease from
more than 20 infectious agents (Exs. 3-172GG,
3-274C). The primary agents of concern in current occupational
settings are the human immunodeficiency virus (HIV),
hepatitis B virus (HBV), and hepatitis C virus (Hepatitis C Virus).
To reduce the
health risk to workers whose duties involve exposure to blood or
other potentially infectious materials, OSHA promulgated the
Bloodborne Pathogens (BBP) standard (29 CFR 1910.1030) on December
6, 1991 (56 FR 64004). The provisions of
the standard were based on the Agency's determination that a
combination of engineering and work practice controls,
personal protective equipment, training, medical surveillance,
hepatitis B vaccination, signs and labels, and other requirements
would minimize the risk of disease transmission.
Needlesticks
and other percutaneous injuries resulting in exposure to blood or
other potentially infectious materials continue to be of
concern due to the high frequency of their occurrence and the
severity of the health effects associated with exposure. The Centers for
Disease Control and Prevention has estimated that healthcare workers
in hospital settings sustain 384,325 percutaneous
injuries involving contaminated sharps annually (Ex. 5-4). When
non-hospital healthcare workers are included, the best
estimate of the number of percutaneous injuries involving
contaminated sharps is 590,164 per year (Ex. 3- 172V). When these
injuries involve exposure to infectious agents, the affected workers
are at risk of contracting disease. Workers may also suffer
from adverse side effects of drugs used for post-exposure
prophylaxis and from psychological stress due to the threat of
infection following an exposure incident.
Since
publication of the BBP standard, a wide variety of medical devices
have been developed to reduce the risk of needlesticks
and other sharps injuries. These "safer medical devices" replace
sharps with non-needle devices or incorporate safety features
designed to reduce the likelihood of injury. In a September 9, 1998,
Request for Information (RFI), OSHA solicited
information on occupational exposure to bloodborne pathogens due to
percutaneous injury (63 FR 48250). Based in part on the
responses to the RFI, the Agency has pursued an approach to minimize
the risk of occupational exposure to bloodborne
pathogens that involves three components. First, the Agency proposed
that the revised Recordkeeping standard (29 CFR 1904)
include a requirement that all percutaneous injuries from
contaminated needles and other sharps be recorded on OSHA logs
(61 FR 4030). Second, OSHA issued a revised compliance directive for
the BBP standard on November 5, 1999, to
reflect advances made in medical technology and treatment. The
directive guides OSHA's compliance officers in enforcing the
standard and ensures that consistent inspection procedures are
followed. Third, the Agency placed amendment of the
bloodborne pathogens standard on its regulatory agenda to more
effectively address sharps injuries.
Congress was
prompted to take action in response to growing concern over
bloodborne pathogen exposures from sharps injuries and in
response to recent technological developments that increase employee
protection. On November 6, 2000, the Needlestick
Safety and Prevention Act was signed into law. The Act directs OSHA
to revise the BBP standard in accordance with
specific language included in the Act.
II. Statutory
Authority
On November 6,
2000, President Clinton signed the Needlestick Safety and Prevention
Act, Pub. L. 106-430. The Act requires OSHA
to revise the BBP standard within six months of the Act's enactment.
To facilitate expeditious completion of this directive,
Congress explicitly exempted OSHA from procedural requirements
generally attending rulemaking under OSH Act 6(b) and
from the procedural requirements of the Administrative Procedure Act
(5 U.S.C. 500 et seq.).
III. Summary
and Explanation
The revisions
to OSHA's BBP standard required under the Needlestick Safety and
Prevention Act can be broadly categorized
into four areas: modification of definitions relating to engineering
controls; revision and updating of the Exposure Control Plan;
solicitation of employee input; and recordkeeping.
The revised
standard adds two additional terms to the definition section found
in paragraph (b) and alters the definition of one other term. It
adds "Sharps with Engineered Sharps Injury Protections" and defines
this term as "a nonneedle sharp or a needle device
used for withdrawing body fluids, accessing a vein or artery, or
administering medications or other fluids, with a built-in
safety feature or mechanism that effectively reduces the risk of an
exposure incident." This term encompasses a broad array of
devices that make injury involving a contaminated sharp less likely,
and includes, but is not limited to, syringes with a sliding
sheath that shields the attached needle after use; needles that
retract into a syringe after use; shielded or retracting
catheters used to access the bloodstream for intravenous
administration of medication or fluids; and intravenous medication
delivery systems that administer medication or fluids through a
catheter port or connector site using a needle that is housed in a
protective covering.
The revised
standard also adds the term "Needleless Systems," which is defined
as "a device that does not use needles for:
(A) The
collection of bodily fluids or withdrawal of body fluids after
initial venous or arterial access is established; (B) the administration
of medication or fluids; or (C) any other procedure involving the
potential for occupational exposure to bloodborne
pathogens due to percutaneous injuries from contaminated sharps." "Needleless
Systems" provide an alternative to needles for
the specified procedures, thereby reducing the risk of percutaneous
injury involving contaminated sharps. Examples of
needleless systems include, but are not limited to, intravenous
medication delivery systems that administer medication or
fluids through a catheter port or connector site using a blunt
cannula or other non-needle connection, and jet injection
systems that deliver subcutaneous or intramuscular injections of
liquid medication through the skin without use of a needle.
The definition
of "Engineering Controls" has been modified to include as examples
"safer medical devices, such as sharps with engineered
sharps injury protections and needleless systems." This change
clarifies that safer medical devices are considered to be
engineering controls under the standard. The term "Engineering
Controls" includes all control measures that isolate or remove a hazard
from the workplace, encompassing not only sharps with engineered
sharps injury protections and needleless systems but
also other medical devices designed to reduce the risk of
percutaneous exposure to bloodborne pathogens. Examples
include blunt suture needles and plastic or mylar-wrapped glass
capillary tubes, as well as controls that are not medical
devices, such as sharps disposal containers and biosafety cabinets.
The expanded
definitions reflect the intent of Congress to have OSHA amend the
BBP standard to clarify
* * * the
direction already provided by OSHA in its Compliance Directive;
namely, that employers who have employees with
occupational exposure to bloodborne pathogens must consider and,
where appropriate, use effective engineering controls,
including safer medical devices, in order to reduce the risk of
injury from needlesticks and from other sharp medical instruments * *
* (Ex. 5-3).
Thus, the
revised definitions do not reflect any new requirements being placed
on employers with regard to protecting workers from
sharps injuries, but are meant only to clarify the original
standard, and to reflect the development of new safer medical devices
since that time.
Paragraph
(c)(1)(iv) of the standard is revised to add new requirements to the
annual review and update of the Exposure Control Plan.
The review and update of the plan is now required to "(A) reflect
changes in technology that eliminate or reduce exposure
to bloodborne pathogens; and (B) document annually consideration and
implementation of appropriate commercially
available and effective safer medical devices designed to eliminate
or minimize occupational exposure." Thus, the additional
provisions require that employers, in their written Exposure Control
Plans, account for innovations in procedure and
technological developments that reduce the risk of exposure
incidents. This would include, but would not be limited to, newly available
medical devices designed to reduce the risk of percutaneous exposure
to bloodborne pathogens. Consideration
and implementation of safer medical devices could be documented in
the Exposure Control Plan by describing the safer
devices identified as candidates for adoption; the method or methods
used to evaluate devices and the results of evaluations;
and justification for selection decisions. This information must be
updated at least annually.
The revised
Exposure Control Plan requirements make clear that employers must
implement the safer medical devices that are
appropriate, commercially available, and effective. No one medical
device is appropriate in all circumstances of use. For purposes of
this standard, an "appropriate" safer medical device includes only
devices whose use, based on reasonable judgment in
individual cases, will not jeopardize patient or employee safety or
be medically contraindicated. Although new devices are
being continually introduced, OSHA recognizes that a safer device
may not be available for every situation. If a safer device is
not available in the marketplace, the employer is not required to
develop any such device. Furthermore, the revised
requirements are limited to the safer medical devices that are
considered to be "effective." For purposes of this standard, an
"effective" safer medical device is a device that, based on
reasonable judgment, will make an exposure incident involving a
contaminated sharp less likely to occur in the application in which
it is used.
Paragraph
(c)(1)(v) of the revised standard now requires that "An employer,
who is required to establish an Exposure Control Plan
shall solicit input from non-managerial employees responsible for
direct patient care who are potentially exposed to
injuries from contaminated sharps in the identification, evaluation,
and selection of effective engineering and work practice
controls and shall document the solicitation in the Exposure Control
Plan." This change represents a new requirement,
which is performance-oriented. No specific procedures for obtaining
employee input are prescribed. This provides the
employer with flexibility to solicit employee input in any manner
appropriate to the circumstances of the workplace. A
dental office employing two hygienists, for example, may choose to
conduct periodic conversations to discuss identification,
evaluation, and selection of controls. A large hospital, on the
other hand, would likely find that an effective process for
soliciting employee input requires the implementation of more formal
procedures. The solicitation of input required by the
standard requires employers to take reasonable steps to obtain
employee input in the identification, evaluation, and
selection of controls. Methods for soliciting employee input may
include involvement in informal problem-solving
groups; participation in safety audits, worksite inspections, or
exposure incident investigations; participation in analysis of
exposure incident data or in job or process hazard analysis;
participation in the evaluation of devices through pilot testing;
and involvement in a safety and health committee properly
constituted and operated in conformance with the National Labor
Relations Act.
Employee input
can serve to assist the employer in overcoming obstacles to the
successful implementation of control measures. A
number of respondents to the RFI indicated that they encountered
some resistance when new devices required staff members
to adopt new techniques, or when staff members perceived that use of
the device might have an adverse effect on the patient
(e.g., Exs. 3-50, 3-79, 3- 99, 3-133). As a way of addressing this
resistance, staff involvement in the selection process can
play an important role in the acceptance and proper use of safer
medical devices (e.g., Exs. 3-18, 3-42, 3-56, 3-88, 3-324,
3-355). According to their experience, the participation of
frontline workers can help to overcome the following
barriers:
Safer
medical devices often require adjustments in technique, and a number
of respondents noted that staff members are often
reluctant to revise practices to which they have become accustomed.
Equipment
compatibility problems. With the broad array of devices being used
in healthcare settings, it is critical to ensure
that devices will work together when necessary.
The need
for continued evaluation of devices and the allotment of sufficient
time for adequate device evaluation. After initial use by employees,
some facilities found it necessary to replace the device originally
selected with a more suitable device.
The Community
Health Network (CHN) of San Francisco provides an example of a
safety and health committee with responsibility
for sharps injury prevention (Ex. 5-5). Representatives of both
labor and management serve on the committee, and are
provided with access to non- confidential information regarding
bloodborne pathogen exposure incidents at CHN facilities. The
committee is responsible for establishing criteria for safer
devices; overseeing device evaluation by representative
groups of device users; and selecting preferred devices for
purchase. The committee is also responsible for developing
safer alternatives to work practices that are associated with
exposure incidents.
The concept of
involving a team in sharps injury prevention programs is supported
by the American Hospital Association (AHA) in
guidelines to assist hospitals and health systems in developing such
programs (Ex. 5-1). According to AHA, a successful
program revolves around communication, education, training, and
collaboration. Among the specific steps recommended are
assembling a multidisciplinary team that includes representation of
frontline workers and departments using devices;
selecting targeted devices for evaluation; pilot-testing of devices;
and collecting data after a device is adopted to evaluate its
impact.
The standard
requires that employers seek input from non-managerial employees
responsible for direct patient care who are potentially
exposed to injuries from contaminated sharps. Employees involved in
administering treatment or performing any procedure in
the presence of an individual receiving care are considered to be
involved in direct patient care. For example, an employee who
uses a needled syringe to collect blood from patients in a nursing
home, or an employee who administers flu
vaccinations in a factory employee health unit, would both be
considered to be involved in direct patient care and engaged in activities
that put them at risk of direct exposure due to needlestick
injuries. Employers may also choose to include other employees in
the request for input, such as lab technicians, housekeeping staff,
maintenance workers, and management-level personnel who
may be at risk of injury involving contaminated sharps. An employer
who is otherwise required to establish an Exposure
Control Plan under the standard, but does not have any
non-managerial employees responsible for direct patient care who are
potentially exposed to injuries from contaminated sharps, is not
required to solicit employee input with respect to this
provision.
The revised
standard does not require employers to request input from all
potentially exposed employees involved in direct patient care;
however, the employees involved by the employer should represent the
range of exposure situations encountered in
the workplace. Input from employees covered by a
collective-bargaining agreement may also be requested through their
authorized bargaining agent.
The revised
standard requires that solicitation of input from employees be
documented in the Exposure Control Plan. Employers can
meet this obligation by identifying the employees who were involved
and describing the process by which input was
requested. Employers should also describe the input obtained with
regard to identification, evaluation, and selection of controls.
Evidence that employee input has been sought can include, for
example, meeting minutes, copies of documents used to request
employee participation, or records of responses received from
employees such as reports evaluating the effectiveness
of a safer medical device in trial applications.
The requirement
for solicitation of input from employees has been designated as
paragraph (c)(1)(v) in the revised standard. The requirement
that the Exposure Control Plan be made available to the Assistant
Secretary of Labor for Occupational Safety and
Health and the Director of the National Institute for Occupational
Safety and Health upon request, previously designated as
paragraph (c)(1)(v), has been moved and is now paragraph (c)(1)(vi)
in the revised standard.
The
recordkeeping requirements of the standard at paragraph (h) have
been amended by adding paragraph (h)(5) to require that employers
maintain a sharps injury log to serve as a tool for identifying high
risk areas and evaluating devices. Paragraph (h)(5)(i) now
states, "The employer shall establish and maintain a sharps injury
log for the recording of percutaneous injuries from
contaminated sharps. The information in the sharps injury log shall
be recorded and maintained in such manner as to protect the
confidentiality of the injured employee. The sharps injury log shall
contain, at a minimum: (A) The type and brand of device
involved in the incident, (B) the department or work area where the
exposure incident occurred, and (C) an explanation of
how the incident occurred." The sharps injury log must be maintained
for the period required by 29 CFR 1904. The
requirement to establish and maintain the log only applies to
employers who are otherwise required to maintain a log of
occupational injuries and illnesses under 29 CFR 1904 (OSHA's
Recordkeeping rule).
The sharps
injury log must include the specified minimum information regarding
the device involved (if known), the location of the incident,
and the description of the events that resulted in the injury. The
level of detail presented should be sufficient to allow ready
identification of the device, location, and circumstances
surrounding an exposure incident (e.g., the procedure being
performed, the body part affected, objects or substances involved
and how they were involved) so that the intended evaluation of
risk and device effectiveness can be accomplished.
Information in
the sharps injury log must be recorded and maintained in a manner
that protects the privacy of the injured employee. If
data from the log are made available to other parties, any
information that directly identifies an employee (e.g., name, address,
social security number, payroll number) or information that could
reasonably be used to identify indirectly a specific
employee (e.g., exact age, date of initial employment) must be
withheld.
The format of
the sharps injury log is not specified. The employer is permitted to
determine the format in which the log is maintained
(e.g., paper or electronic), and may include information in addition
to that required by the standard, so long as the privacy of
injured workers is protected. The Agency recognizes that many
employers already compile reports of percutaneous
exposure incidents in a variety of ways. Existing mechanisms for
collecting these reports will be considered sufficient to
meet the requirements of the standard for maintaining a sharps
injury log, provided that the information gathered meets the
minimum requirements specified in the standard, and the
confidentiality of the injured employee is protected.
Under newly
published revisions to OSHA's Recordkeeping rule (29 CFR 1904),
employers are required to record sharps injuries
involving contaminated objects on the OSHA 300 Log of Work-Related
Injuries and Illnesses and the OSHA 301 Injury and
Illness Incident Report (the new forms replace the current 200 and
101 forms). When the revisions become effective,
employers may elect to use the OSHA 300 and 301 forms to meet the
sharps injury log requirements, provided two conditions
are met. First, the employer must enter the type and brand of the
device on either the 300 or 301 form. Second, the
employer must maintain the records in a way that segregates sharps
injuries from other types of work-related injuries and
illnesses, or allows sharps injuries to be easily separated. For
example, if OSHA 300 and 301 records are maintained on a
computer, the employer must ensure that the computer is able to
produce a record of sharps injuries that does not
include other types of work-related injuries and illnesses (i.e.,
through using a program that allows for sorting of entries by
injury type). If records are kept on paper forms, the employer would
need to use a separate page of the 300 Log for sharps
injuries.
The revisions
to the Recordkeeping rule will not become effective until January 1,
2002, at the earliest, and until then many sharps injuries
involving contaminated objects will not be recordable on the OSHA
log. Therefore, employers must keep a separate sharps
log from the effective date of this rule until the revised
Recordkeeping rule becomes effective.
These revisions
to the BBP standard become effective April 18, 2001. Exposure
Control Plans that are reviewed and updated on or
after this effective date must reflect the requirements of the
revised standard. Percutaneous exposure incidents that occur on
or after this effective date must be recorded on the sharps injury
log.
OSHA's BBP
standard, including the amendments herein promulgated, is applicable
to general industry and shipyard employment (as
referenced in 29 CFR 1915.1030).
IV. Economic
Analysis
Incremental
Costs of the Mandated Revisions to the Standard
OSHA has
determined that the total cost of this action is $33,814,991 per
year, and thus, that it is not an economically significant
regulatory action within the meaning of Executive Order 12866.
However, the rule is defined as a significant rule under the
Executive Order, and has been reviewed by the Office of Management
and Budget. This amendment to the final standard does
not involve any new engineering requirements to protect workers from
sharps injuries, but it does include two new
recordkeeping requirements: First, the amended standard requires
employers to "establish and maintain a sharps injury log for the
recording of percutaneous injuries * * *" However, for recordable
needlestick incidents, OSHA already requires employers to
collect much of the information needed for developing such a log
under other rules, the Recording and Reporting
Occupational Injuries and Illnesses regulation (29 CFR 1904) in
particular. Moreover, OSHA has recently published
revisions to 29 CFR 1904 that would cover the remaining, previously
nonrecordable needlestick injuries. Second, the current
action requires any employer "who is required to establish an
Exposure Control Plan" to "solicit input from non-managerial
employees responsible for direct patient care who are potentially
exposed to injuries from contaminated sharps in the
identification, evaluation, and selection of effective engineering
and work practice controls and shall document the
solicitation in the Exposure Control Plan." The methodology OSHA has
used for computing costs for each requirement of the amended
standard is presented in the next two sections.
Cost of
Establishing and Maintaining a Sharps Injury Log
The rule
requires employers to maintain a log for all needlestick and sharps
injuries. At a minimum, the sharps injury log must contain: "(A)
The type and brand of device involved in the incident, (B) the
department or work area where the exposure incident
occurred, and (C) an explanation of how the incident occurred." The
costs attributable to the log correspond directly to the number
of needlestick and sharps injuries. The International Health Care
Worker Safety Center (IHCWSC) provides the best
available estimate of the number of needlestick injuries (Ex.
3-172V). IHCWSC has computed that 590,164 needlestick and
sharps injuries occur annually.
Needlestick and
sharps injury cases will require an effort pertaining to collection
of data on the type and brand of device, the department or
work area where the incident occurred, and an explanation of how the
incident occurred. Because the amount of information
required to be collected is limited, OSHA estimates that it will
require an average of five minutes per case (0.08 hours) to
collect the data and enter it onto the separate log. Assuming that
the task of collecting information related to the incident
and entry onto the log will be conducted by an individual with the
skill level of a Personnel Training and Labor Relations
Specialist, an hourly wage of $26.32 is used to compute cost. (The
hourly wage for Personnel Training and Labor Relations
Specialist as reported in the Bureau of Labor Statistics
Occupational Employment Statistics Survey is $19.03; benefits are
computed at 38.3 percent of the hourly wage.) Thus, the incremental
annual cost of the separate sharps injury log is: (590,164 cases)
x (0.08 hours/case) x ($26.32/hour) = $1,294,352.
In summary,
OSHA estimates that the total annual cost of maintaining a sharps
injury log will be $1,294,352. This estimate is likely to
overstate true costs for at least three reasons. First, for already
recordable incidents, the data needed to maintain a separate sharps
injury log are already collected and entered into a log format for
other purposes, namely for the requirements set forth by 29
CFR Part 1904. It is unlikely that the data will need to be
"re-entered." Instead, businesses are likely to develop
procedures for automating the process or for organizing log
information, thereby significantly reducing the incremental
costs associated with this incremental action. For nonrecordable
cases, the data collection required by the Needlestick
Safety and Prevention Act and this revision to the BBP standard will
be required under 29 CFR Part 1904 (once revisions
to Part 1904 become effective), so that the incremental costs
associated with the separate sharps injury log are short-term
in nature. Finally, and perhaps most importantly, the above cost
estimate significantly overstates costs because it includes
costs for all establishments in SIC 80. Under revisions to 29 CFR
Part 1904, SICs 801, 802, 803, 804, 807, and 809 are
exempted from recordkeeping requirements under Part 1904 and will
thus not be required by this amendment to the BBP standard to
keep a needlestick and sharps injury log. This is potentially
significant because SICs 801, 802, 803, 804, 807, and 809
constitute 31 percent of employment for SIC 80, though not
necessarily 31 percent of sharps injuries.
Cost of
Solicitation of Employee Input
The cost
associated with solicitation of employee input is comprised of three
components: (1) The initial solicitation, conducted by a
manager; (2) the employee response; and (3) documentation of the
solicitation in the Exposure Control Plan.
The cost of the
initial solicitation is likely to vary with establishment size,
number of incidents, and employee interest. The establishments
that will be affected are those that are: (1) Required to develop an
Exposure Control Plan, and (2) have employees who
are involved in direct patient care and who are potentially exposed
to needlestick injuries. The overwhelming majority of
such establishments are in SIC 80, Health Services. County Business
Patterns reports that in 1997 (1997 data are used as the
most recent year for which data are available using the SIC
reporting system), there were 502,724 establishments
in SIC 80. OSHA estimates that the initial solicitation or call for
employee input will require an average of 15 minutes (0.25
hours) of managerial time. The wage rate of a Medicine and Health
Care Manager is $33.22 per hour, including
fringe benefits. (The hourly wage for a Medicine and Health Care
Manager reported in the Bureau of Labor Statistics
Occupational Employment Statistics Survey is $24.02; benefits are
computed at 38.3 percent of the hourly wage.) The estimated cost of
the initial solicitation is: (502,724
establishments) x (0.25 hours/establishment) x ($33.22/ hour) =
$4,175,080.
The cost
associated with the employee response varies with the number of
employees and the response rate to the initial solicitation.
According to County Business Patterns, there were 11,348,141
individuals employed in SIC 80 in 1997. OSHA estimates that
it will require 15 minutes (0.25 hours) of employee time to respond
to the solicitation and that approximately 33 percent of
employees will respond. Using a wage rate of $25.90 (which is the
total hourly compensation in 1998 for professional
specialty and technical employees in Health Services reported in the
Bureau of Labor Statistics publication Employer Costs
for Employee Compensation, 1986-1988), the estimated costs
associated with employee response are: (11,348,141
employees) x (33% response rate) x (0.25 hours/ employee) x
($25.90/hour) = $24,248,140.
Note that it is
implicitly assumed that input is solicited from all employees. This
assumption will result in an overstatement of costs because
the standard requires that input be solicited only from the fraction
of employees who are involved in direct patient care
and who are potentially exposed to needlestick injuries.
Finally, the
revised standard requires that the employer document the
solicitation in the Exposure Control Plan. Because the affected
employers are already required to establish a Plan, the incremental
effort associated with this documentation will be small. OSHA
estimates that it will require only 15 minutes (0.25 hours) of
managerial time. Thus, the total annual cost of documenting the
solicitation in the Exposure Control Plan is estimated to be: (502,724
establishments) x (0.25 hours/establishment) x ($33.22/ hour) =
$4,175,080.
In summary,
OSHA has estimated the total cost of the solicitation to be
$32,598,300 ($4,175,080 + $24,248,140 + $4,175,080).
This estimate is likely to overstate the cost because employers have
several avenues for achieving this requirement of
the standard, many of which will reduce costs. For example,
employers are not required to solicit input from all employees
and could meet the requirement by, for example, consulting a
properly constituted safety committee consisting of a subset of
employees. In fact, recent state legislation has mandated sharps
safety committees in a number of states. In these
situations, the only incremental cost associated with the
solicitation mandated by this amendment to the BBP standard will be
documentation of the solicitation in the Exposure Control Plan.
Total Cost and
Cost Per Establishment
According to
the above analysis, the maximum total annual cost of this action is
$33,892,653, consisting of $1,294,352 associated with
maintaining a sharps injury log and $32,598,300 associated with
soliciting and documenting employee input into the
Exposure Control Plan. This amounts to $67 per establishment, per
year, which will not cause significant economic impact on
either large or small affected establishments.
V. Unfunded
Mandates
OSHA has
determined that, for the purposes of section 202 of the Unfunded
Mandates Reform Act of 1995 (2 U.S.C. 1532), this
rule does not include any federal mandate that may result in
increased expenditures by state, local, or tribal governments in
the aggregate of more than $100 million, or increased expenditures
by the private sector of more than $100 million.
Moreover, the Agency has determined that for purposes of section 203
of the Act, this rule does not significantly or uniquely affect
these entities.
Background
The Unfunded
Mandates Reform Act was enacted in 1995. While much of the Act is
designed to assist the Congress in determining
whether its actions will impose costly new mandates on state, local,
and tribal governments, the Act also includes requirements to
assist federal agencies to make this same determination with respect
to regulatory actions.
Analysis
As discussed in
Section IV, Economic Analysis, this rule will have incremental costs
of $34 million per year, all of which are associated with
maintaining the sharps injury log and soliciting and documenting
employee information. These total costs represent an
average cost of $67 per year per affected establishment. OSHA does
not anticipate any disproportionate budgetary
effects upon any particular region of the nation, or particular
state, local or tribal governments, or urban or rural communities.
VI.
Environmental Impacts
The National
Environmental Policy Act requires that "major Federal actions
significantly affecting the quality of the human environment" be
accompanied by a statement addressing the environmental impact of
the proposed action. (42 U.S.C. 4332(C))
Department of Labor regulations establish a criteria for determining
when an environmental impact statement is required in a
rulemaking proceeding:
Preparation of
an environmental impact statement will always be required for
proposals for promulgation, modification or revocation of
health standards which will significantly affect air, water or soil
quality, plant or animal life, the use of land or other aspects
of the human environment.
29 CFR 11.10
(a)(3)
OSHA has
concluded that no significant environmental impacts would result
from this rulemaking. This final standard expands the universe of
engineering controls permissible for reducing occupational exposure
to bloodborne pathogens. It also widens the scope of
Exposure Control Plan review, requires maintenance of a sharps
injury log, and mandates the solicitation of input from
employees on the identification, evaluation, and selection of
effective engineering and work practice controls. The Agency has not
identified any impacts of these requirements on the environment.
VII. Federalism
This standard
has been reviewed in accordance with the Executive Order on
Federalism (Executive Order 13132, 64 FR 43255, Aug. 10,
1999). The order requires that agencies, to the extent possible,
refrain from limiting state policy options; consult with
states prior to taking actions that would restrict state policy
options; and take such action only when there is clear
constitutional authority and the presence of a problem of national
scope. Executive Order 13132 also provides that agencies shall
not promulgate regulations that have significant Federalism
implications and impose substantial direct compliance
costs on state or local governments, unless the agency consults with
state and local officials early in the process of developing
the proposed regulation and provides a summary Federalism impact
statement in the preamble of the final rule. Finally, the
Order provides for preemption of state law only if there is a clear
Congressional intent for the agency to do so, and provides
that any such preemption is to be limited to the extent possible.
Under Section
6(b) of the Executive Order, an agency is exempt from state
consultation requirements if it is promulgating a regulation that
is required by statute. The amendments to OSHA's BBP standard
codified in this rule were explicitly written by Congress and
enacted as Public Law 106-430. Moreover, Congress clearly intended
the revised BBP standard to have the same legal
effect as other standards issued under 6(b) of the Occupational
Safety and Health Act of 1970. Nonetheless, OSHA has
consulted extensively with those 25 States and territories that
operate OSHA-approved State plans with regard to OSHA policy
on safe needle devices and the requirements of the subject
legislation.
Section 18 of
the OSH Act expresses Congress' intent to preempt state laws
relating to issues on which Federal OSHA has promulgated
occupational safety and health standards. Under the OSH Act, a state
can avoid preemption only if it submits, and receives
Federal approval for, a State plan for the development and
enforcement of standards. OSHA-approved State plans operate
under authority of State law and must adopt occupational safety and
health standards which, among other things, must be
at least as effective in providing safe and healthful employment and
places of employment as Federal standards.
In Gade v.
National Solid Wastes Management Assoc., the U.S. Supreme Court
reaffirmed the view that Section 18 of the OSH Act
effectively preempts states without approved plans from adopting or
enforcing any laws that directly, substantially,
and specifically regulate occupational safety and health. 505 U.S.
88, 107 (1992). However, needlestick laws in states
without an OSHA-approved State plan would not be affected to the
extent to which they regulate the occupational safety and
health conditions of state or local government employees (see
Section 3(5) of the OSH Act).
VIII. State
Plan States
The 23 states
and 2 territories that operate their own federally approved
occupational safety and health plans must adopt a comparable
amended standard within six months of the publication date of a
final Federal OSHA standard. The States and territories
with this obligation include: Alaska, Arizona, California,
Connecticut (for State and local government employees only), Hawaii,
Indiana, Iowa, Kentucky, Maryland, Michigan, Minnesota, Nevada, New
Mexico, New York (for State and local
government employees only), North Carolina, Oregon, Puerto Rico,
South Carolina, Tennessee, Utah, Vermont, Virginia,
Virgin Islands, Washington, and Wyoming. Until such time as state
and territorial standards are amended, Federal OSHA will
provide interim enforcement assistance, as appropriate.
IX. Paperwork
Reduction Act
This final rule
contains new collection of information (paperwork) requirements in
revisions to the Bloodborne Pathogen Standard
(1910.1030 and 1915.1030) made as a result of the Needlestick Safety
and Prevention Act (Pub. L. 106-430). These new
paperwork requirements are subject to review by the Office of
Management and Budget (OMB) under the Paperwork
Reduction Act of 1995 (PRA 95), 44 U.S.C. 3501 et seq., and its
regulation at 5 CFR Part 1320. OSHA solicits public
comments concerning its estimate of the burden hours and costs for
the revised paperwork requirements. The Agency will
summarize the comments received and include a summary of them in its
request to OMB to approve the information
collection requirements; they will also become a matter of public
record. OSHA seeks this information as part of its continuing
effort to reduce paperwork and respondent burden. The information
helps to ensure that requested data can be provided in the
desired format, reporting burden (time and financial resources) is
minimized, collection instruments are clearly understood, and
the impact of collection requirements on respondents can be properly
assessed.
The Needlestick
Safety and Prevention Act requires employers, who have exposure
control plans in accordance with § 1910.1030
(c)(1)(iv), "to review and update such plans to reflect changes in
technology that eliminate or reduce exposure to bloodborne
pathogens." The exposure control plan must also "document
consideration and implementation of appropriate commercially
available and effective safer medical devices designed to eliminate
or minimize occupational exposure." Employers
required to have exposure control plans must also "solicit input
from non-managerial employees responsible for direct patient
care who are potentially exposed to injuries from contaminated
sharps in the identification, evaluation, and selection of
effective engineering and work practice controls and shall document
the solicitation in the Exposure Control Plan."
The Needlestick
Safety and Prevention Act also requires employers, who currently
maintain a log of occupational injuries and illnesses
under 29 CFR 1904, to "establish and maintain a sharps injury log
for the recording of percutaneous injuries from
contaminated sharps." The information in the sharps injury log must
be recorded and maintained so that the confidentiality
of the injured worker is protected. The log must contain at least
the following information: "(A) the type and brand of device
involved in the incident; (B) the department or work area where the
exposure incident occurred; and (C) an explanation of
how the incident occurred."
Respondents are
not required to comply with collection of information (paperwork)
requirements unless a currently valid OMB control
number is displayed (Sec. 1320.5 (b)(2)(i)). OSHA will publish the
OMB control number as soon as it receives
approval on its ICR for the revised collections. A copy of the
Agency's revised ICR for the BBP standard is available for
inspection and copying as part of Docket ICR1218-0180(2000) in the
OSHA Docket Office, U.S. Department of Labor, Room
N-2625, 200 Constitution Avenue, NW., Washington, DC 20210, or you
may request a mailed copy by telephoning
Todd Owen at (202) 693-2444.
Comments on the
ICR should be submitted to the Docket Office, Docket Number ICR-0180
(2001), OSHA, U.S. Department of
Labor, Room N- 2625, 200 Constitution Avenue, NW., Washington, DC
20210, telephone: (202) 693-2350.
Commenters may transmit written comments of 10 pages or less in
length by facsimile to (202) 693-1648.
The Department
and OMB are particularly interested in comments that
Evaluate
whether the proposed collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information will have practical
utility; Evaluate
the accuracy of the Agency's estimate of the burden of the proposed
collection of information, including the validity
of the methodology and assumptions used; Enhance
the quality, utility, and clarity of the information to be
collected; and Minimize
the burden of the collection of information on those who are to
respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques
or other forms of
information technology, e.g., permitting electronic submission of
responses.
Title:
Bloodborne Pathogens standard (29 CFR 1910.1030).
OMB Number:
1218-0180 (Revision).
Frequency:
Employers must: annually review their exposure control plans;
initially establish and maintain a sharps injury log; as necessary,
make injury recordings in the log; and solicit input from
non-managerial employees.
Affected
Public: The respondents are those employers that must maintain an
exposure control plan, and employers who are required to
maintain a log of occupational injuries and illnesses under 29 CFR
part 1904.
Total
Respondents: 502,724 establishments.
Average time
per response: Three to five minutes for employers to record
needlestick incidents; fifteen minutes for employers to
solicit non-managerial employees on effective engineering and work
practice controls; fifteen minutes for employers to
modify their existing exposure control plans.
Estimated
Burden Hours: 49,180 hours for employers to log needlestick
incidents; 125,681 hours for employers to solicit non- managerial
employees; and 125,681 hours for employers to update existing
exposure control plans.
Estimated Cost
(Operation and Maintenance): 0.
X. Authority
and Signature
This document
was prepared under the direction of Charles N. Jeffress, Assistant
Secretary of Labor for Occupational Safety and
Health, U.S. Department of Labor, 200 Constitution Avenue, NW.,
Washington, DC 20210. Accordingly,
pursuant to sections 4, 6, and 8 of the Occupational Safety and
Health Act of 1970 (29 U.S.C. 653, 655, 657) and the
Needlestick Safety and Prevention Act (Pub. L. 106-430, 114 Stat.
1901, November 6, 2000); and Secretary of Labor's Order
No. 3-2000 (65 FR 50017), 29 CFR part 1910 is amended as set forth
below.
List of
Subjects in 29 CFR Part 1910
Blood, Blood
diseases, Health, Healthcare, Hepatitis B virus, Hepatitis C virus,
Hospitals, Human immunodeficiency virus, Needlestick,
Occupational safety and health, Sharps injury.
Signed at
Washington, DC, this 10th day of January 2001.
Charles N.
Jeffress, Assistant
Secretary of Labor for Occupational Safety and Health.
XI. Amended
Final Rule and Appendix
The
Occupational Safety and Health Administration is amending part 1910
of title 29 of the Code of Federal Regulations as follows:
PART 1910 --
OCCUPATIONAL SAFETY AND HEALTH STANDARDS
1. The
authority citation for 29 CFR part 1910, subpart Z, is revised to
read as follows:
Authority:
Sections 4, 6, and 8 of the Occupational Safety and Health Act of
1970 (29 U.S.C. 653, 655, 657); Secretary of Labor's
Order No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR
35736), 1-90 (55 FR 9033), 6-96 (62 FR 111), or 3-2000
(65 FR 50017), as applicable; and 29 CFR part 1911.
All of subpart
Z issued under Sec. 6(b) of the Occupational Safety and Health Act,
except those substances that have exposure limits
listed in Tables Z-1, Z-2, and Z-3 of 29 CFR 1910.1000. The latter
were issued under Sec. 6(a) (29 U.S.C. 655(a)).
Section
1910.1000, Tables Z-1, Z-2 and Z-3 also issued under 5 U.S.C. 553,
Section 1910.1000 Tables Z-1, Z-2, and Z-3 not issued
under 29 CFR part 1911 except for the arsenic (organic compounds),
benzene, and cotton dust listings.
Section
1910.1001 also issued under section 107 of the Contract Work Hours
and Safety Standards Act (40 U.S.C. 333) and 5 U.S.C.
553.
Section
1910.1002 not issued under 29 U.S.C. 655 or 29 CFR part 1911; also
issued under 5 U.S.C. 553.
Sections
1910.1018, 1910.1029 and 1910.1200 are also issued under 29 U.S.C.
653.
Section
1910.1030 is also issued under Pub. L. 106-430, 114 Stat. 1901.
* * * *
*
2. Section
1910.1030 is amended as follows:
A. In Sec.
1910.1030, paragraph (b), the definition for "Engineering Controls"
is revised and definitions are added in alphabetical
order to read as set forth below:
B. Paragraph
(c)(1)(iv) is revised to read as set forth below:
C. Paragraph
(c)(1)(v) is redesignated paragraph (c)(1)(vi), and a new paragraph
(c)(1)(v) is added to read as set forth below:
D. A new
paragraph (h)(5) is added to read as set forth below:
§ 1910.1030
Bloodborne pathogens.
(b) Engineering
controls means controls (e.g., sharps disposal containers,
self-sheathing needles, safer medical devices, such as sharps with
engineered sharps injury protections and needleless systems) that
isolate or remove the bloodborne pathogens hazard from the
workplace. Needleless
systems means a device that does not use needles for:
(1) The
collection of bodily fluids or withdrawal of body fluids after
initial venous or arterial access is established;
(2) The
administration of medication or fluids; or
(3) Any other
procedure involving the potential for occupational exposure to
bloodborne pathogens due to percutaneous injuries from
contaminated sharps.
Sharps with
engineered sharps injury protections means a nonneedle sharp or a
needle device used for withdrawing body fluids,
accessing a vein or artery, or administering medications or other
fluids, with a built-in safety feature or mechanism that
effectively reduces the risk of an exposure incident. * * * * *
(c) * * *
(1) * * *
(iv) The
Exposure Control Plan shall be reviewed and updated at least
annually and whenever necessary to reflect new or modified tasks
and procedures which affect occupational exposure and to reflect new
or revised employee positions with occupational
exposure. The review and update of such plans shall also:
(A) Reflect
changes in technology that eliminate or reduce exposure to
bloodborne pathogens; and
(B) Document
annually consideration and implementation of appropriate
commercially available and effective safer medical devices
designed to eliminate or minimize occupational exposure.
(v) An
employer, who is required to establish an Exposure Control Plan
shall solicit input from non-managerial employees responsible for
direct patient care who are potentially exposed to injuries from
contaminated sharps in the identification, evaluation, and
selection of effective engineering and work practice controls and
shall document the solicitation in the Exposure
Control Plan.
* * * *
*
(h) * * *
(5) Sharps
injury log. (i) The employer shall establish and maintain a sharps
injury log for the recording of percutaneous injuries from
contaminated sharps. The information in the sharps injury log shall
be recorded and maintained in such manner as to protect
the confidentiality of the injured employee. The sharps injury log
shall contain, at a minimum:
(A) The type
and brand of device involved in the incident,
(B) The
department or work area where the exposure incident occurred, and
(C) An
explanation of how the incident occurred.
(ii) The
requirement to establish and maintain a sharps injury log shall
apply to any employer who is required to maintain a log of occupational
injuries and illnesses under 29 CFR 1904.
(iii) The
sharps injury log shall be maintained for the period required by 29
CFR 1904.6.
* * * *
*
[FR Doc.
01-1207 Filed 1-17-01; 8:45 am]
BILLING CODE
4510-26-P
|